Raymond James Financial
IONS icon

Raymond James Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Raymond James Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Sell
235,121
-22,089
-9% -$1.74M 0.01% 1569
2025
Q4 		$20.3M Buy
257,210
+16,786
+7% +$1.26M 0.01% 1430
2025
Q3 		$15.7M Buy
240,424
+29,832
+14% +$1.46M 0.01% 1587
2025
Q2 		$8.32M Buy
210,592
+61,902
+42% +$2.03M ﹤0.01% 2005
2025
Q1 		$4.49M Buy
148,690
+43,071
+41% +$1.41M ﹤0.01% 2405
2024
Q4 		$3.69M Buy
+105,619
New +$3.95M ﹤0.01% 2523

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James Financial's IONS Position: Q1 2026 in Review

Raymond James Financial reduced its Ionis Pharmaceuticals (IONS) stake by 8.6% in Q1 2026, selling an estimated $1.74M and leaving 235,121 shares worth $17.7M. The position accounts for 0.01% of the portfolio, ranked #1569.

Raymond James Financial first reported a position in IONS in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.3M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Raymond James Financial held 235,121 shares of Ionis Pharmaceuticals worth $17.7M as of Q1 2026.
  • Raymond James Financial sold 22,089 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.74M.
  • Ionis Pharmaceuticals made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1569 holding.
  • Raymond James Financial first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Ionis Pharmaceuticals position peaked at $20.3M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.